Los Angeles Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-23,180
| Closed | -$554K | – | 1518 |
|
2019
Q4 | $554K | Buy |
23,180
+4,870
| +27% | +$116K | ﹤0.01% | 989 |
|
2019
Q3 | $491K | Hold |
18,310
| – | – | ﹤0.01% | 993 |
|
2019
Q2 | $497K | Buy |
18,310
+5,700
| +45% | +$155K | ﹤0.01% | 1042 |
|
2019
Q1 | $438K | Buy |
+12,610
| New | +$438K | ﹤0.01% | 1123 |
|
2018
Q3 | – | Sell |
-28,341
| Closed | -$1.07M | – | 1533 |
|
2018
Q2 | $1.07M | Sell |
28,341
-290
| -1% | -$10.9K | 0.01% | 873 |
|
2018
Q1 | $935K | Buy |
28,631
+23,940
| +510% | +$782K | 0.01% | 848 |
|
2017
Q4 | $228K | Sell |
4,691
-2,459
| -34% | -$120K | ﹤0.01% | 1241 |
|
2017
Q3 | $386K | Buy |
+7,150
| New | +$386K | ﹤0.01% | 1081 |
|
2016
Q3 | – | Sell |
-9,745
| Closed | -$230K | – | 1303 |
|
2016
Q2 | $230K | Buy |
+9,745
| New | +$230K | ﹤0.01% | 1127 |
|
2014
Q2 | – | Sell |
-13,730
| Closed | -$356K | – | 1321 |
|
2014
Q1 | $356K | Buy |
+13,730
| New | +$356K | ﹤0.01% | 998 |
|